InVitae (NVTA) Misses Q3 EPS by 1c

InVitae (NYSE: NVTA) reported Q3 EPS of ($0.71), $0.01 worse than the analyst estimate of ($0.70). Revenue for the quarter came in at $2.2 million versus the consensus estimate of $2.55 million.

For earnings history and earnings-related data on InVitae (NVTA) click here.

You May Also Be Interested In

• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• UBS Reiterates Buy Rating on Option Care Health (OPCH) Following Check-in Call Ahead of Quiet Period
• Activist Corvex seeks Whitbread board seat over strategy concerns